Behaviour and prefrontal protein differences in C57BL/6N and 129 X1/SvJ mice

Brain Research Bulletin

Volumn 116, Issue , 2015, Pages 16-24

  Zhang, Xiaofan ^a,b   Li, Qi ^b   Wong, Naikei ^b   Zhang, Min ^a   Wang, Wei ^a   Bu, Bitao ^a   McAlonan, Grainne Mary ^b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

129X1 SvJ; Amphetamine test; C57BL 6N; Prepulse inhibition; Proteomics

Indexed keywords

AMPHETAMINE; BEHAVIOR PROTEIN; PREFRONTAL PROTEIN; PROTEIN; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CELL COMMUNICATION; CONTROLLED STUDY; FEMALE; MALE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROXY; SCREENING; SENSORY GATING; SIGNAL TRANSDUCTION; 129 MOUSE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PROTEOMICS; SEXUAL DEVELOPMENT; SPECIES DIFFERENCE; STARTLE REFLEX; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AMPHETAMINE; ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM STIMULANTS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; MALE; MICE, 129 STRAIN; MICE, INBRED C57BL; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; PREFRONTAL CORTEX; PROTEOMICS; REFLEX, STARTLE; SENSORY GATING; SEX CHARACTERISTICS; SPECIES SPECIFICITY;

EID: 84930666261     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2015.05.003     Document Type: Article

References (56)

1. Belknap J.K., Crabbe J.C., Young E. Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology (Berl) 1993, 112:503-510. 10.1007/bf02244901.
2. Bogerts B., Meertz E., Schönfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia: a morphometric study of brain volume and shrinkage. Arch. Gen. Psychiatry 1985, 42:784-791. 10.1001/archpsyc.1985.01790310046006.
3. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Arch. Gen. Psychiatry 1990, 47:181-188. 10.1001/archpsyc.1990.01810140081011.
4. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001, 156:234-258. 10.1007/s002130100810.
5. Brose N. For better or for worse: complexins regulate SNARE function and vesicle fusion. Traffic 2008, 9:1403-1413. 10.1111/j.1600-0854.2008.00758.x.
6. Brown G.K. Pyruvate dehydrogenase E1 alpha deficiency. J. Inherit. Metab. Dis. 1992, 15:625-633. 10.1007/bf01799619.
7. Bryant C.D., Zhang N.N., Sokoloff G., Fanselow M.S., Ennes H.S., Palmer A.A., McRoberts J.A. Behavioral differences among C57BL/6 substrains: implications for transgenic and knockout studies. J. Neurogenet. 2008, 22:315-331. 10.1080/01677060802357388.
8. Cabiscol E., Piulats E., Echave P., Herrero E., Ros J. Oxidative stress promotes specific protein damage in Saccharomyces cerevisiae. J. Biol. Chem. 2000, 275:27393-27398. 10.1074/jbc.m003140200.
9. Cadenhead K.S., Geyer M.A., Braff D.L. Impaired startle prepulse inhibition and habituation. Am. J. Psychiatry 1993, 150:1862-1867. 10.1176/ajp.150.12.1862.
10. Chen R., Zhang M., Park S., Gnegy M.E. C57BL/6J mice show greater amphetamine-induced locomotor activation and dopamine efflux in the striatum than 129S2/SvHsd mice. Pharmacol. Biochem. Behav. 2007, 87:158-163. 10.1016/j.pbb.2007.04.012.
11. Clayton J.A., Collins F.S. NIH to balance sex in cell and animal studies. Nature 2014, 509:282-283. 10.1038/509282a.
12. Crawley J.N. Unusual behavioral phenotypes of inbred mouse strains. Trends Neurosci. 1996, 19:181-182. 10.1016/s0166-2236(96)20021-9.
13. Feng J. Microtubule: a common target for parkin and Parkinson's disease toxins. Neuroscientist 2006, 12:469-476. 10.1177/1073858406293853.
14. Flores G., Wood G.K., Liang J.-J., Quirion R., Srivastava L.K. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. J. Neurosci. 1996, 16:7366-7375.
15. Gardner P.R., Nguyen D., White C.W. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:12248-12252. 10.1073/pnas.91.25.12248.
16. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?. Trends Neurosci. 1996, 19:177-181. 10.1016/s0166-2236(96)20020-7.
17. Gershenfeld H., Paul S. Towards a genetics of anxious temperament: from mice to men. Acta Psychiatr. Scand. 1998, 98:56-65. 10.1111/j.1600-0447.1998.tb05968.x.
18. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res. Bull. 1990, 25:485-498.
19. Greenamyre J.T. Glutamatergic influences on the basal ganglia. Clin. Neuropharmacol. 2001, 24:65-70. 10.1016/0361-9230(90)90241-q.
20. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4746-4751. 10.1073/pnas.081071198.
21. He M., Shippenberg T.S. Strain differences in basal and cocaine-evoked dopamine dynamics in mouse striatum. J. Pharmacol. Exp. Ther. 2000, 293:121-127.
22. Hefner K., Whittle N., Juhasz J., Norcross M., Karlsson R.-M., Saksida L.M., Bussey T.J., Singewald N., Holmes A. Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J. Neurosci. 2008, 28:8074-8085. 10.1523/jneurosci.4904-07.2008.
23. Ikegami K., Heier R.L., Taruishi M., Takagi H., Mukai M., Shimma S., Taira S., Hatanaka K., Morone N., Yao I. Loss of α-tubulin polyglutamylation in ROSA22 mice is associated with abnormal targeting of KIF1A and modulated synaptic function. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3213-3218. 10.1073/pnas.0611547104.
24. Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur. Arch. Psychiatry Clin. Neurosci. 2000, 250:274-285. 10.1007/s004060070002.
25. Jiang Z., Rompala G.R., Zhang S., Cowell R.M., Nakazawa K. Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons. Biol. Psychiatry 2013, 73:1024-1034. 10.1016/j.biopsych.2012.12.004.
26. Karp N.A., Griffin J.L., Lilley K.S. Application of partial least squares discriminant analysis to two-dimensional difference gel studies in expression proteomics. Proteomics 2005, 5:81-90. 10.1002/pmic.200400881.
27. Kinoshita N., Kimura K., Matsumoto N., Watanabe M., Fukaya M., Ide C. Mammalian septin Sept2 modulates the activity of GLAST, a glutamate transporter in astrocytes. Genes Cells 2004, 9:1-14. 10.1111/j.1356-9597.2004.00696.x.
28. Kumari V., Aasen I., Sharma T. Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr. Res. 2004, 69:219-235. 10.1016/j.schres.2003.09.010.
29. Kuzmin A., Johansson B. Reinforcing and neurochemical effects of cocaine: differences among C57, DBA, and 129 mice. Pharmacol. Biochem. Behav. 2000, 65:399-406. 10.1016/s0091-3057(99)00211-7.
30. Landis S.C., Amara S.G., Asadullah K., Austin C.P., Blumenstein R., Bradley E.W., Crystal R.G., Darnell R.B., Ferrante R.J., Fillit H. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 2012, 490:187-191. 10.1038/nature11556.
31. Li Q., Cheung C., Wei R., Hui E.S., Feldon J., Meyer U., Chung S., Chua S.E., Sham P.C., Wu E.X. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS ONE 2009, 4:e6354. 10.1371/journal.pone.0006354.
32. Ly C.V., Verstreken P. Mitochondria at the synapse. Neuroscientist 2006, 12:291-299. 10.1177/1073858406287661.
33. Maier C.M., Chan P.H. Book review: role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 2002, 8:323-334. 10.1177/107385840200800408.
34. Matsuo N., Takao K., Nakanishi K., Yamasaki N., Tanda K., Miyakawa T. Behavioral profiles of three C57BL/6 substrains. Front. Behav. Neurosci. 2010, 4. 10.3389/fnbeh.2010.00029.
35. McAlonan G.M., Daly E., Kumari V., Critchley H.D., van Amelsvoort T., Suckling J., Simmons A., Sigmundsson T., Greenwood K., Russell A. Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain 2002, 125:1594-1606. 10.1093/brain/awf150.
36. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. Br. J. Med. Psychol. 1961, 34:103-116. 10.1111/j.2044-8341.1961.tb00936.x.
37. Meltzer H.Y. Relevance of dopamine autoreceptors for psychiatry. Schizophr. Bull. 1980, 6:456-475. 10.1093/schbul/6.3.456.
38. Meyer U., Feldon J., Schedlowski M., Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 2005, 29:913-947. 10.1016/j.neubiorev.2004.10.012.
39. Miner L.L. Cocaine reward and locomotor activity in C57BL/6J and 129/SvJ inbred mice and their F1 cross. Pharmacol. Biochem. Behav. 1997, 58:25-30. 10.1016/s0091-3057(96)00465-0.
40. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13:1161-1169. 10.1038/nn.2647.
41. Owen E., Logue S., Rasmussen D., Wehner J. Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience 1997, 80:1087-1099. 10.1016/s0306-4522(97)00165-6.
42. Perry W., Minassian A., Lopez B., Maron L., Lincoln A. Sensorimotor gating deficits in adults with autism. Biol. Psychiatry 2007, 61:482-486. 10.1016/j.biopsych.2005.09.025.
43. Pycock C., Horton R. Dopamine-dependent hyperactivity in the rat following manipulation of GABA mechanisms in the region of the nucleus accumbens. J. Neural Transm. 1979, 45:17-33. 10.1007/bf01243878.
44. Ralph R.J., Paulus M.P., Geyer M.A. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. J. Pharmacol. Exp. Ther. 2001, 298:148-155.
45. Rutter M. Diagnosis and definition of childhood autism. J. Autism Child. Schizophr. 1978, 8:139-161. 10.1007/BF01537863.
46. Shumyatsky G.P., Malleret G., Shin R.-M., Takizawa S., Tully K., Tsvetkov E., Zakharenko S.S., Joseph J., Vronskaya S., Yin D. Stathmin, a gene enriched in the amygdala, controls both learned and innate fear. Cell 2005, 123:697-709. 10.1016/j.cell.2005.08.038.
47. Simpson E.M., Linder C.C., Sargent E.E., Davisson M.T., Mobraaten L.E., Sharp J.J. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat. Genet. 1997, 16:19-27. 10.1038/ng0597-19.
48. Strenzke N., Chanda S., Kopp-Scheinpflug C., Khimich D., Reim K., Bulankina A.V., Neef A., Wolf F., Brose N., Xu-Friedman M.A. Complexin-I is required for high-fidelity transmission at the endbulb of held auditory synapse. J. Neurosci. 2009, 29:7991-8004. 10.1523/jneurosci.0632-09.2009.
49. Sturm M., Becker A., Schroeder A., Bilkei-Gorzo A., Zimmer A. Effect of chronic corticosterone application on depression-like behavior in C57BL/6N and C57BL/6J mice. Genes Brain Behav. 2015, 14:292-300. 10.1111/gbb.12208.
50. Südhof T.C., Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science 2009, 323:474-477. 10.1126/science.1161748.
51. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatry 1994, 51:139-154. 10.1001/archpsyc.1994.03950020063007.
52. Takahashi K., Nagai T., Kamei H., Maeda K., Matsuya T., Arai S., Mizoguchi H., Yoneda Y., Nabeshima T., Takuma K. Neural circuits containing pallidotegmental GABAergic neurons are involved in the prepulse inhibition of the startle reflex in mice. Biol. Psychiatry 2007, 62:148-157. 10.1016/j.biopsych.2006.06.035.
53. Tenn C.C., Fletcher P.J., Kapur S. Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr. Res. 2003, 64:103-114. 10.1016/s0920-9964(03)00009-4.
54. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805. 10.1016/s0140-6736(03)14289-4.
55. Vercauteren F.G., Flores G., Ma W., Chabot J.G., Geenen L., Clerens S., Fazel A., Bergeron J.J., Srivastava L.K., Arckens L. An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia. Proteomics 2007, 7:3569-3579. 10.1002/pmic.200700379.
56. Wang Y., Lam K.S., Lam J.B., Lam M.C., Leung P.T., Zhou M., Xu A. Overexpression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice. Mol. Endocrinol. 2007, 21:972-986. 10.1210/me.2006-0249.